Comp Set ORTINGLOBE LASA× MANGALAM× BIOFILCHEM× + VINEETLAB + KREBSBIO + ALPA + BALPHARMA + NATCAPSUQ + NECLIFE + AAREYDRUGS + MEDICAMEQ + MEDICO
In ₹ Crore except Per Share
Latest Annual
ORTINGLOBE
FY26
LASA
FY26
MANGALAM
FY26
BIOFILCHEM
FY26
Peer
Average
Valuation — at last close P/E — — — 17.11× 17.11× P/B 8.16× 0.47× ◆ 0.45×2.21× 1.04× +683% EV/EBITDA ◆ -10.14×-1.14× -10.12× 72.85× 20.53× -149% Market Cap ₹10.1 Cr ₹23.4 Cr ₹46.1 Cr ₹47.6 Cr ₹39 Cr -74% Growth Revenue CAGR 3Y -74.44% -42.11% — ◆ -1.85%-21.98% -239% Revenue CAGR 5Y -58.50% -34.11% — ◆ -4.50%-19.30% -203% Net Income CAGR 3Y — — — 70.67% 70.67% Revenue YoY (latest Q) -70.85% -93.87% -0.40% ◆ 91.99%-0.76% -9222% Net Income YoY (latest Q) -92.65% ◆ 83.05%44.64% -95.47% 10.74% -963% Profitability EBITDA Margin -1030.05% -112.98% -6.42% ◆ 2.29%-39.04% -2539% Net Income Margin -736.72% -135.60% -19.13% ◆ 9.81%-48.31% -1425% Return on Common Equity -46.06% -51.13% -35.23% ◆ 13.81%-24.18% -90% Return on Capital Employed -46.34% -51.42% -22.60% ◆ 1.83%-24.06% -93% Return on Assets -17.57% -40.63% -13.03% ◆ 5.94%-15.91% -10% Credit & Quality Total Debt/Equity 0.81× 0.20× 1.02× ◆ 0.14×0.45× +79% Interest Coverage -470.77× -89.13× -2.04× ◆ 37.37×-17.93× -2525% Scale — latest FY Revenue / Total Income ₹0.1 Cr ₹25.1 Cr ₹232 Cr ₹28.4 Cr ₹95.2 Cr -100% Net Income −₹0.7 Cr −₹34.1 Cr −₹44.4 Cr ₹2.8 Cr −₹25.2 Cr +97% Total Assets ₹4.6 Cr ₹66.3 Cr ₹315 Cr ₹42.8 Cr ₹141 Cr -97% EPS ₹-0.91 ₹-6.8 ₹-28.05 ₹1.71 ₹-11.05 +92% Book Value per Share ₹1.52 ₹9.9 ₹65.11 ₹13.25 ₹29.42 -95%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › » Latest: FY26 · Standalone CHART » ALPHA AI » COMP » FA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95% .
